Search





Search





Markets
/
Stocks
/
rlay
/

Relay Therapeutics Inc

RLAY

Add to Watchlist

18.830USD

-0.620-3.19%

Close 07-31 16:00（ET）Quotes delayed by 15 min

4.06BMarket Cap

LossP/E TTM

Relay Therapeutics Inc

18.830

-0.620-3.19%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

RLAY Cash Flow Statement

You can access the annual and quarterly cash flow statements of Relay Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

30.18%-51.11M

22.47%-44.87M

17.27%-62.12M

16.06%-55.26M

-45.48%-73.21M

35.12%-57.87M

0.42%-75.08M

4.03%-65.83M

25.04%-50.32M

-56.25%-89.19M

-13.99%-75.40M

-20.16%-68.60M

-36.52%-67.13M

-43.75%-57.08M

-24.34%-66.14M

-102.89%-57.09M

-205.43%-49.17M

-12.57%-39.71M

-121.30%-53.20M

-35.00%-28.14M

308.83%46.64M

-54.97%-35.27M

-37.34%-24.04M

-38.47%-20.84M

-106.49%-22.33M

---22.76M

---17.50M

---15.05M

---10.82M

Net income from continuing operations

4.90%-73.29M

27.78%-54.89M

15.84%-74.15M

23.68%-70.38M

5.31%-77.06M

8.97%-76.00M

-34.03%-88.11M

6.39%-92.21M

13.64%-81.39M

-23.69%-83.50M

21.91%-65.73M

-28.28%-98.50M

-51.89%-94.24M

-0.07%-67.50M

-38.36%-84.17M

60.30%-76.79M

-47.08%-62.05M

-291.22%-67.46M

-68.62%-60.83M

-623.69%-193.40M

-69.51%-42.18M

247.52%35.28M

-83.39%-36.08M

-52.39%-26.72M

-75.48%-24.89M

---23.91M

---19.67M

---17.54M

---14.18M

Operating gains losses

-58.28%504.00K

-55.10%599.00K

-45.28%748.00K

141.37%3.30M

-13.41%1.21M

-2.98%1.33M

0.29%1.37M

2.55%1.37M

16.54%1.40M

17.92%1.38M

31.95%1.36M

39.54%1.33M

22.77%1.20M

12.77%1.17M

2.08%1.03M

-0.42%956.00K

6.09%975.00K

13.38%1.03M

10.84%1.01M

10.98%960.00K

6.98%919.00K

6.92%912.00K

44.01%913.00K

25.18%865.00K

28.79%859.00K

--853.00K

--634.00K

--691.00K

--667.00K

Other non-cash items

51.03%-782.00K

60.71%-857.00K

65.36%-1.10M

57.64%-1.39M

56.43%-1.60M

40.56%-2.18M

-10.50%-3.18M

-49.52%-3.29M

-81.71%-3.67M

-852.99%-3.67M

-945.88%-2.88M

-503.11%-2.20M

-396.18%-2.02M

-156.53%-385.00K

-49.25%340.00K

-99.56%546.00K

345.10%681.00K

4764.29%681.00K

8275.00%670.00K

105696.58%123.55M

147.66%153.00K

102.20%14.00K

100.70%8.00K

83.80%-117.00K

---321.00K

---635.00K

---1.14M

---722.00K

--0.00

Change in working capital

179.04%11.92M

-294.55%-2.82M

54.29%-3.50M

-114.86%-1.91M

-289.03%-15.08M

107.03%1.45M

73.42%-7.65M

35.03%12.84M

7.61%7.98M

-423.38%-20.60M

-8702.75%-28.79M

234.22%9.51M

214.55%7.41M

-57.48%6.37M

96.14%-327.00K

-77.67%2.85M

-96.98%2.36M

117.41%14.98M

-943.77%-8.46M

1058.91%12.75M

13867.98%78.08M

-23023.12%-86.02M

-156.87%-811.00K

-23.24%1.10M

-69.34%559.00K

---372.00K

--1.43M

--1.82M

-Change in receivables

----

-100.00%0.00

100.00%0.00

306.86%211.00K

-104.62%-133.00K

4961.32%5.15M

-100.00%-12.00K

-188.70%-102.00K

88.87%-65.00K

-102.51%-106.00K

-100.01%-6.00K

100.14%115.00K

---584.00K

--4.21M

--74.05M

---82.65M

----

-Change in prepaid expenses

287.33%7.36M

2500.00%3.82M

58.97%-3.97M

22.64%5.69M

-727.58%-3.93M

-84.61%147.00K

-16.81%-9.66M

74.65%4.64M

-3068.75%-475.00K

-92.66%955.00K

47.09%-8.27M

3117.05%2.66M

-97.17%16.00K

191.51%13.02M

-29.11%-15.64M

-102.64%-88.00K

-65.32%566.00K

546.15%4.47M

-156.32%-12.11M

316.50%3.33M

525.29%1.63M

1.96%-1.00M

-486.96%-4.72M

998.88%800.00K

225.48%261.00K

---1.02M

---805.00K

---89.00K

---208.00K

-Change in payables and accrued expense

206.38%3.67M

-163.63%-6.53M

---507.00K

---953.00K

---3.45M

--10.27M

----

-Change in other current assets

----

--0.00

-100.00%0.00

100.00%0.00

--0.00

--22.00K

---22.00K

----

-Change in other current liabilities

104.81%384.00K

-107.27%-615.00K

--469.00K

---1.07M

---7.99M

35370.83%8.46M

----

---24.00K

110.84%9.00K

118.07%15.00K

100.00%0.00

-100.00%0.00

---83.00K

---82.00K

--15.00M

----

Cash from non-recurring investing activities

Cash from operating activities

30.18%-51.11M

22.47%-44.87M

17.27%-62.12M

16.06%-55.26M

-45.48%-73.21M

35.12%-57.87M

0.42%-75.08M

4.03%-65.83M

25.04%-50.32M

-56.25%-89.19M

-13.99%-75.40M

-20.16%-68.60M

-36.52%-67.13M

-43.75%-57.08M

-24.34%-66.14M

-102.89%-57.09M

-205.43%-49.17M

-12.57%-39.71M

-121.30%-53.20M

-35.00%-28.14M

308.83%46.64M

-54.97%-35.27M

-37.34%-24.04M

-38.47%-20.84M

-106.49%-22.33M

---22.76M

---17.50M

---15.05M

---10.82M

Investing cash flow

Net cash from continuing investing activities

----

--1.00K

-100.44%-1.00K

136.36%26.00K

-78.43%384.00K

-100.00%0.00

-61.53%227.00K

-99.27%11.00K

-7.05%1.78M

-94.91%118.00K

-71.84%590.00K

-19.06%1.50M

-31.46%1.92M

163.18%2.32M

20.68%2.10M

389.97%1.86M

486.97%2.79M

1275.00%880.00K

300.92%1.74M

-8.45%379.00K

-53.33%476.00K

-89.30%64.00K

-81.86%433.00K

-77.66%414.00K

-67.56%1.02M

--598.00K

--2.39M

--1.85M

--3.14M

Capital expenditures

----

--1.00K

----

136.36%26.00K

-78.43%384.00K

-100.00%0.00

-61.53%227.00K

-99.27%11.00K

-7.05%1.78M

-94.91%118.00K

-71.84%590.00K

-19.06%1.50M

-31.46%1.92M

163.18%2.32M

20.68%2.10M

389.97%1.86M

486.97%2.79M

1275.00%880.00K

300.92%1.74M

-8.45%379.00K

-53.33%476.00K

-89.30%64.00K

-81.86%433.00K

-77.90%414.00K

-67.56%1.02M

--598.00K

--2.39M

--1.87M

--3.14M

Net cash flow from disposal of fixed assets

----

--1.00K

-100.44%-1.00K

136.36%26.00K

-78.43%384.00K

-100.00%0.00

-61.53%227.00K

-99.27%11.00K

-7.05%1.78M

-94.91%118.00K

-71.84%590.00K

-19.06%1.50M

-31.46%1.92M

163.18%2.32M

20.68%2.10M

389.97%1.86M

486.97%2.79M

1275.00%880.00K

300.92%1.74M

-8.45%379.00K

-53.33%476.00K

-89.30%64.00K

-81.86%433.00K

-77.66%414.00K

-67.56%1.02M

--598.00K

--2.39M

--1.85M

--3.14M

Net cash flow from business transactions

----

100.00%0.00

----

---83.00K

---25.13M

----

Net cash flow from investment products

-23.22%32.90M

22.30%35.46M

131.54%39.72M

64.99%75.17M

248.05%42.85M

-51.51%29.00M

-275.02%-125.94M

-13.68%45.56M

-84.06%12.31M

141.35%59.80M

145.73%71.95M

16.65%52.78M

170.47%77.23M

50.44%-144.62M

29.53%29.28M

-12.28%45.24M

52.99%-109.59M

-282.13%-291.78M

10.24%22.61M

-41.43%51.58M

-553.67%-233.15M

-309.22%-76.36M

116.70%20.51M

124.67%88.06M

--51.39M

--36.49M

--9.46M

---357.00M

--0.00

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-22.52%32.90M

22.29%35.46M

131.49%39.73M

64.97%75.15M

303.24%42.47M

-51.41%29.00M

-276.78%-126.16M

-11.17%45.55M

-86.02%10.53M

140.61%59.68M

162.50%71.36M

18.18%51.28M

167.01%75.31M

49.81%-146.94M

30.79%27.19M

66.44%43.39M

51.89%-112.38M

-283.07%-292.75M

3.56%20.79M

-70.26%26.07M

-563.80%-233.62M

-312.89%-76.42M

183.68%20.07M

124.42%87.65M

1702.13%50.37M

--35.90M

--7.08M

---358.85M

---3.14M

Financing cash flow

Cash flow from continuous financing activities

--138.78M

16.75%934.00K

-99.99%17.00K

-57.65%653.00K

-100.00%0.00

-96.35%800.00K

2214.33%218.89M

-25.87%1.54M

3671.94%48.92M

1779.76%21.92M

-96.69%9.46M

4.21%2.08M

46.89%1.30M

-99.70%1.17M

31592.35%285.87M

78.06%2.00M

-57.03%883.00K

685635.71%384.01M

-99.79%902.00K

1305.38%1.12M

485.47%2.06M

124.67%56.00K

367309.48%426.19M

-113.88%-93.00K

-93.05%351.00K

---227.00K

--116.00K

--670.00K

--5.05M

Net cash flow from common stock issuance/repurchase

--137.09M

22.00%427.00K

-100.00%0.00

-42.16%653.00K

----

-98.39%350.00K

2229.99%218.16M

-30.61%1.13M

--47.73M

3866.67%21.78M

-96.71%9.36M

43.10%1.63M

----

-99.86%549.00K

--284.74M

--1.14M

----

--383.35M

----

--0.00

--427.80M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

----

--647.00K

--5.02M

Proceeds from stock option exercised by employees

--1.69M

12.67%507.00K

-97.68%17.00K

----

219.15%450.00K

670.53%732.00K

-8.83%413.00K

-8.48%1.19M

-77.15%141.00K

-91.53%95.00K

-47.26%453.00K

46.89%1.30M

-6.66%617.00K

24.28%1.12M

-23.37%859.00K

-57.03%883.00K

1080.36%661.00K

104.07%902.00K

205.45%1.12M

485.47%2.06M

-87.30%56.00K

268.33%442.00K

1495.65%367.00K

1110.34%351.00K

--441.00K

--120.00K

--23.00K

--29.00K

Net cash flow from other financing activities

----

--0.00

----

100.00%0.00

----

100.00%0.00

-51075.00%-2.05M

---460.00K

--0.00

---668.00K

---4.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

--138.78M

16.75%934.00K

-99.99%17.00K

-57.65%653.00K

-100.00%0.00

-96.35%800.00K

2214.33%218.89M

-25.87%1.54M

3671.94%48.92M

1779.76%21.92M

-96.69%9.46M

4.21%2.08M

46.89%1.30M

-99.70%1.17M

31592.35%285.87M

78.06%2.00M

-57.03%883.00K

685635.71%384.01M

-99.79%902.00K

1305.38%1.12M

485.47%2.06M

124.67%56.00K

367309.48%426.19M

-113.88%-93.00K

-93.05%351.00K

---227.00K

--116.00K

--670.00K

--5.05M

Net cash flow

Beginning cash balance

-32.48%85.35M

-39.26%93.82M

-15.08%116.20M

-38.51%95.66M

-13.68%126.41M

0.29%154.48M

-7.92%136.83M

-5.05%155.57M

-5.14%146.44M

-56.88%154.03M

34.71%148.61M

34.28%163.85M

-45.39%154.37M

54.55%357.22M

-58.00%110.31M

-53.71%122.02M

-36.97%282.70M

-58.74%231.14M

90.42%262.65M

270.12%263.60M

947.17%448.52M

1772.00%560.16M

242.82%137.93M

-82.78%71.22M

-89.86%42.83M

--29.92M

--40.23M

--413.47M

--422.38M

Current period cash flow changes

492.16%120.57M

69.83%-8.47M

-226.82%-22.38M

209.59%20.54M

-436.75%-30.75M

-269.73%-28.07M

225.18%17.64M

-22.94%-18.74M

-3.70%9.13M

96.26%-7.59M

-97.80%5.43M

-30.19%-15.24M

105.90%9.48M

-493.42%-202.85M

883.58%246.91M

-1131.23%-11.71M

13.11%-160.67M

146.19%51.56M

-107.46%-31.51M

-101.43%-951.00K

-751.42%-184.93M

-964.79%-111.64M

4194.94%422.23M

117.87%66.71M

418.50%28.39M

--12.91M

---10.31M

---373.24M

---8.91M

Ending cash balance

115.27%205.93M

-32.48%85.35M

-39.26%93.82M

-15.08%116.20M

-38.51%95.66M

-13.68%126.41M

0.29%154.48M

-7.92%136.83M

-5.05%155.57M

-5.14%146.44M

-56.88%154.03M

34.71%148.61M

34.28%163.85M

-45.39%154.37M

54.55%357.22M

-58.00%110.31M

-53.71%122.02M

-36.97%282.70M

-58.74%231.14M

90.42%262.65M

270.12%263.60M

947.17%448.52M

1772.00%560.16M

242.82%137.93M

-82.78%71.22M

--42.83M

--29.92M

--40.23M

--413.47M

Free cash flow

30.55%-51.11M

22.47%-44.87M

----

16.03%-55.29M

-41.25%-73.59M

35.20%-57.87M

0.89%-75.31M

6.08%-65.84M

24.54%-52.10M

-50.36%-89.31M

-11.35%-75.99M

-18.92%-70.10M

-32.86%-69.05M

-46.34%-59.40M

-24.22%-68.24M

-106.70%-58.95M

-212.57%-51.97M

-14.86%-40.59M

-124.48%-54.94M

-34.16%-28.52M

297.67%46.16M

-51.27%-35.34M

-23.04%-24.47M

-25.59%-21.26M

-67.29%-23.35M

---23.36M

---19.89M

---16.93M

---13.96M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Relay Therapeutics Inc Generate?



Relay Therapeutics Inc generated -235.46M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Relay Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Relay Therapeutics Inc's operating cash flow increased by 5.48% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Relay Therapeutics Inc Spend on Capital Expenditures?



Relay Therapeutics Inc spent 410.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Relay Therapeutics Inc's Financing Cash Flow Changed?



Relay Therapeutics Inc used 1.60M in financing activities in the latest quarter.

What is free cash flow and why does it matter for RLAY?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Relay Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -235.87M reflecting a 6.08% change from the previous year.